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Ababa University, Debre Zeit; 4 SPANA UK, 14 John Street, LondonHistoplasma capsulatum var. farciminosum (HCF), causing Epizo-
otic Lymphangitis (EZL), is endemic in parts of Africa including,
Ethiopia, Senegal and Gambia. Despite its high prevalence, impact
on animal welfare and socio-economic importance, there is little
evidence upon which to build contextually relevant disease
control programmes. The performance and availability of diag-
nostic tests currently used by clinicians is problematic. Methods
such as pattern recognition of clinical signs and microscopy lack
sensitivity, and other options are either not commercially avail-
able or not readily feasible (e.g. culture). This is a signiﬁcant
barrier to further understanding this disease within endemic
countries. This study aimed to validate a nested PCR method to
conﬁrm the presence of HCF in equine clinical samples. Ethical
approval was obtained from the University of Liverpool and the
College of Veterinary Medicine and Agriculture. Twenty-nine
horses with suspected EZL were included from topographically
varied regions of Ethiopia. Clinical examination was recorded and
lesion locations drawn onto equine silhouettes. Blood samples
and aspirates of pus from unruptured cutaneous nodules were
obtained before treatment provided by SPANA. Blood and clinical
data were collected from a further 20 horses with no cutaneous
EZL lesions. Giemsa stained impression smears of pus and blood
were examined microscopically. Aliquots of heat-inactivated pus
and blood were inoculated onto Whatman FTA cards and im-
ported to the UK with Defra approved licensing. A nested PCR
targeting the ITS region*, was used to identify samples containing
HCF, and all PCR products were sequenced. HCF was conﬁrmed in
FTA card pus samples from 24 horses, additionally, 23 blood
samples were positive from EZL suspected cases. The nested PCR
compared favourably overmicroscopic examination of pus, where
characteristic HCF yeast bodies were detected in only 14 of the 24
PCR positive samples examined. All nested PCR ampliﬁcation
products were conﬁrmed as Histoplasma spp. by sequencing.
Sequencing of cloned PCR amplicons suggested at least two sub-
groups of HCF based on single nucleotide polymorphisms. These
techniques allow the rapid diagnosis of HCF directly from equine
clinical samples and offer a useful epidemiological tool. The
identiﬁcation of HCF in blood raises questions about the patho-
genesis of HCF in horses and warrants further investigation.
*Jiang, B. et. al. (2000) Journal of clinical microbiology 38 (1): 241-
245.
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versity, USAEquine arteritis virus (EAV) is a member of the Arteriviridae
family. EAV infects equidae and can persist in the reproductive
tract of stallions only. Stallions persistently infected shed the virus
in their semen and spread the virus in the horse population
during breeding. Moreover, infection may cause abortion in
pregnant mares and the death of young foals. OIE prescribes viral
isolation (VI) on cell culture to detect EAV for international trade.
However, a recent study showed that the real-time reverse
transcription-PCR (RT-qPCR) assay is as sensitive as VI for
detecting EAV in semen [1]. The main challenge to EAV surveil-
lance is detecting EAV to prevent costly outbreaks, considering in
particular the limited number of viral nucleotides targeted, in
some samples. The aim of our studywas to increase the sensitivity
of the OIE-recommended RT-qPCR method by combining it with
an unbiased ampliﬁcation method using the Phi29 polymerase
coupled to a high-density resequencing microarray (RMA) to
genotype the viruses detected. Sixty different samples were used
in this study. Of the 48 EAV-positive samples, 31 were from
semen, 12 were from virus isolation cell culture supernatants and
ﬁve were tissue samples from the lungs, spleen or liver of one
aborted foetus, three young foals and an adult. Our results
showed that isothermal ampliﬁcation polymerase signiﬁcantly
increased the ratio of ampliﬁcation from a factor ranging from 102
to 107 compared to the OIE-recommended RT-qPCR method [2].
To genotype the viruses detected, we combined the unbiased
ampliﬁcation of nucleic acids with a RMA. The two EAV sequences
tiled on the microarray cover a region located in ORF 1 coding for
the non-structural protein 9. Surprisingly, the phylogenic tree
obtained with the nsp 9 nucleotide sequences retrieved from the
microarray was able to separate strains into the NA and EU groups
and divided the EU group into subgroups EU-1 and EU-2 [2]. In
conclusion, this method can be recommended for the detection of
EAV in semen and aborted foetuses, especially when viral load is
very low. In addition, this study conﬁrmed and validated the
usefulness of the high-density resequencing DNA microarray for
both the diagnosis of equine viral diseases and the genotyping of
RNA viruses such as equine arteritis virus.
1. Miszczak, F., et al., Evaluation of two magnetic-bead-
based viral nucleic acid puriﬁcation kits and three real-
time reverse transcription-PCR reagent systems in two
TaqMan assays for equine arteritis virus detection in
semen. J Clin Microbiol, 2011. 49(10): p. 3694-6.
2. Hans, A., et al., Combination of an unbiased ampliﬁca-
tion method and a resequencing microarray for
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EP is a tick-borne infection, caused by T. equi and B. caballi.
Affected animal presents non-speciﬁc signs while introduction of
the infection in free areas is due to the movement of inapparent
carriers. Laboratory diagnosis of EP is generally requested for the
conﬁrmation of clinical suspects and sanitary certiﬁcation of an-
imals for trade. OIE-prescribed tests are serological methods i.e.
ELISA and indirect immunoﬂuorescence (IFAT). Even practitioners
mostly request only serological tests for conﬁrmation of suspect
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targeting the rRNA 18s gene (1, 2), were adopted for their optimal
performance. This study presents and discusses the results of the
use of RT-PCRs in conjunction with ELISA (VMRD, USA) and IFAT
(Fuller Laboratories, USA) that were used to analyse 274 horse
sera. For comparison of results, PCRwas used as reference method
since sequencing of derived amplicons conﬁrmed them as spe-
ciﬁc. The B. caballi RT-PCR detected 14 positive samples, none
conﬁrmed in ELISA, while the IFAT had a sensitivity (Se) of 50% (7/
14) and a speciﬁcity (Sp) of 87.7 % (228/260). The T. equi detected
137 positive samples with the ELISA showing a Se of 67.2% (92/
137) and an Sp of 83.2% (114/137) and the IFAT, a Se of 86.1% (118/
137) and an Sp of 81% (111/137). For both parasites, the IFAT
presented a limited major sensitivity when compared to the
ELISA. Results for B. caballi are preliminary as number of samples
recruited is limited. In particular, for T. equi the serological tests
showed a high agreement and a relatively high speciﬁcity. An
initial evaluation of the correlation between the PCR result and
clinical status of the animal was carried out deﬁning as cases
those presenting an EP acute form based on temperature >38C
and at least one of the following signs, jaundice, anaemia, and
petechial haemorrhages together with a PCR positive result. Of
the PCR positive horses for B. caballi and T. equi, only 28.7% and
19.7% respectively were deﬁned as cases, possibly due to parasite
persistence beyond the acute form. Seropositve results of PCR
negative samples could be due to sterilization of infected horses,
occurring spontaneously or following treatment with a longer
persistence of antibodies as usually occurs in most infections. An
additional value of the use of quantitative PCR is that treatment
efﬁcacy may be monitored especially in view of the side effects
this possess. This study demonstrates that the simultaneous use
of PCR with serological tests increases the diagnostic probability
to deﬁne the sanitary state for EP for the purposes stated above
and underlines the need for revision of the prescribed diagnostic
tests for trade that should include more sensitive methods.
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Eastern and Venezuelan equine encephalitis cause signiﬁcant
disease in both horses and humans.
Effective equine diagnostics (passive surveillance of cases with
compatible clinical syndromes) can serve as advance warning for
human illnesses. In Central and South America, there are serious
difﬁculties in obtaining quality reagents for EEE and VEE di-
agnostics (per Dr. Alfonso Clavijo, Pan American Health Organi-
zation (PAHO), personal communication). Utilizing the genome of
Sindbis virus (SINV), a relatively nonpathogenic human alphavi-
rus, as a vector, a chimeric SIND/VEE virus expressing all of the
structural proteins of the VEE TC-83 vaccine strain has been
developed (Paessler 2003,Wang 2007). The nonstructural protein
genes and cis-acting RNA genome elements from wild-type SINV
strain AR339, and the structural protein genes from either North
American EEEV strain FL93- 939, or from the naturally murine-
attenuated SA strain BeAr436087, are included in the SIND/EEE
chimeras. In collaboration with PAHO, MIDA, and the InstitutoGORGAS, the National Veterinary Services Laboratories have ac-
quired these Sindbis/Alphavirus chimeras from Dr. Scott Weaver
of the University of Texas Medical Branch to validate proposed
diagnostic assays. Validation of diagnostic tests that can be per-
formed at biosafety level-2 will be beneﬁcial for use in both the
United States and in other countries. Chimeric virus propagation
was performed. Direct comparison of the SIND/EEE chimera to
wild-type EEE virus was performed using OIE approved protocols
for EEE IgM Enzyme-linked Immunosorbent Assay (ELISA) and
Plaque Reduction Neutralization Test (PRNT). Testing was per-
formed utilizing sera from naturally infected horses, determined
to be positive by previous diagnostic testing. With the goal of
developing inexpensive, easily performed diagnostics, the chi-
meras were tested without inactivation, using the methods pre-
viously mentioned. Antigen at a 1:10 dilution provided
consistently valid results with varying concentrations of both
conjugate and serum. Additional testing of inactivated chimeras
will also be performed. In addition to the increased safety to
humans who are conducting the diagnostic testing, proposed use
of chimeric strains in diagnostics will improve the ability of North,
South and Central American laboratories to easily and inexpen-
sively detect infection in animals, thereby leading to improved
prevention of infection in both humans and other equids.
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Equine herpesvirus 5 (EHV-5) infection has recently been asso-
ciated with equine multinodular pulmonary ﬁbrosis in horses. To
more completely understand EHV-5 pathogenesis and determine
viral and host contributions, further in vivo and in vitro studies are
needed. However, current techniques are unable to rapidly, spe-
ciﬁcally, and quantitatively characterize EHV-5 infection. The aim
of this project was to develop a TaqMan real-time PCR assay to
quantify EHV-5 in clinical and cell culture samples, and use this
test to describe viral replication over time in primary equine
respiratory epithelial cells (EREC)s. Primers and a probe were
designed to target gene E11 of EHV-5 for TaqMan real-time PCR.
Speciﬁcity was veriﬁed by testing multiple isolates of EHV-5, as
well as DNA from other equine herpesviruses. A plasmid con-
taining the target DNA was generated to create a standard curve
and quantify viral copy number. TaqMan real-time PCR was per-
formed on DNA isolated from clinical samples. In addition, ERECs
were inoculated with EHV-5, and cells and supernatants were
collected daily for 12 days following inoculation and TaqMan real-
time PCR was performed to asses EHV-5 infection and replication.
